Rocaltrol and Neutrophil count increased - a phase IV clinical study of FDA data

Summary:

Neutrophil count increased is reported as a side effect among people who take Rocaltrol (calcitriol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Norvasc, and have Constipation.

The phase IV clinical study analyzes which people have Neutrophil count increased when taking Rocaltrol. It is created by eHealthMe based on reports of 7,521 people who have side effects when taking Rocaltrol from the FDA, and is updated regularly.

What is Rocaltrol?

Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,562 Rocaltrol users. Check the latest studies of Rocaltrol.

What is Neutrophil count increased?

Neutrophil count increased (excess than normal number of neutrophil a type of blood cell) is found to be associated with 943 drugs and 1,167 conditions by eHealthMe. Check the latest studies of Neutrophil count increased.

On Jul, 09, 2026

7,521 people reported to have side effects when taking Rocaltrol.
Among them, 19 people (0.25%) have Neutrophil count increased.

Could Rocaltrol cause Neutrophil count increased?

Among these 19 people:

How long have people been on Rocaltrol when they have Neutrophil count increased? *

What is the gender of people who have Neutrophil count increased when taking Rocaltrol? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Neutrophil count increased when taking Rocaltrol? *

What are other drugs people take besides Rocaltrol? *

What are other side effects people have besides Neutrophil count increased? *

White Blood Cell Count Increased: 10 people, 52.63%
High Blood Pressure: 7 people, 36.84%
C-Reactive Protein Increased: 7 people, 36.84%
Fever: 6 people, 31.58%
Platelet Count Increased: 6 people, 31.58%
Blood Urea Increased: 6 people, 31.58%
Red Blood Cell Count Decreased: 6 people, 31.58%
Blood Creatinine Increased: 5 people, 26.32%
Inflammation: 5 people, 26.32%
Insomnia (sleeplessness): 5 people, 26.32%

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 4 people, 21.05%
Joint Pain: 4 people, 21.05%
Iron Deficiency Anaemia: 4 people, 21.05%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 21.05%
Diabetes: 4 people, 21.05%
Constipation: 4 people, 21.05%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 15.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Rocaltrol and have Neutrophil count increased?

- Check whether Neutrophil count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocaltrol:

Rocaltrol (7,562 reports)

Browse all side effects of Rocaltrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neutrophil count increased:

Neutrophil count increased (943 drugs)

Browse all the conditions that are associated with Neutrophil count increased:

Neutrophil count increased (1,167 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Rocaltrol) and Rocaltrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.